Pharmanex® - The Measurable Difference  
pharmanews products company science opportunity contact
2005 Extraordinary Year for Pharmanex Global R&D
Pharmanews
pharmanews archive
pharmanews sign up
newsroom
pharmanex scientists
research centers & laboratories
6S quality process
scientific advisory board
feedback

 

 

 

nu skin enterprises
nu skin
big planet
Newsroom
press releases
media coverage
global media quotes
scientific expert resource guide
product press kits
company press kits
streaming video
find a global PR contact
media contact
Pharmanex Launches Estera™, The Future Of Women's Hormonal Health

While Female Hormones are Getting a Bad Rap, Pharmanex Is Giving them a Compliment

PROVO, UT — January 05, 2005 — Pharmanex announces the launch of a new product line to promote women's hormonal health throughout the three different stages of a woman's adult life. The product's primary functions are to help the body safely metabolize estrogen, to balance hormones and to manage common hormonal symptoms.

The new product line, Estera™, was developed specifically for women and addresses three main phases of life: the mensus and child-bearing years, the perimenopause and menopause years and the postmenopause years. This is one of the first product lines to address all three stages of an adult woman's life.

"The Estera line is designed as an independent hormone balancing system," said Lori Blackner, D.Ph., senior scientist for Pharmanex and chief developer of Estera. "The ingredients help women to naturally and safely metabolize estrogen and to balance hormones. These products will help women experience a new level of health and quality of life."

Pharmanex scientists set out to produce a proprietary blend of ingredients designed to address three main areas of concern:

  • To promote the safe and healthy metabolism of estrogen
  • To assist the balance of healthy hormone levels
  • To address symptoms specific to the three phases of an adult woman's life, from periodic bloating and weight gain, breast discomfort, occasional anxiousness and sleepiness, mild mood swings, hot flashes, and night sweats, to cardiovascular health and bone concerns.

Product Line
The Estera™ line launches with three products—each product targeting a particular phase. The foundation of each product addresses all three areas of concern with a patent-pending blend of phytoestrogens and enzyme inducers. These ingredients are formulated to help with present symptoms as well as help protect the body later in life. Additional ingredients target symptoms specific to each phase. For instance, women in their childbearing years are commonly affected by PMS. But even for those with no symptoms, it is important to take steps now to maintain good health throughout life. Estera™ is the first line of products on the market that is formulated to deal with all three concerns in a single product line.

  • Estera™ Phase I Women's Balance Formula provides relief from common PMS symptoms*.
  • Estera™ Phase II Women's Transitions Formula helps relieve common symptoms associated with perimenopause.*
  • Estera™ Phase III Women's Maintenance Formula helps relieve common symptoms associated with postmenopause. *

For more information, log on to www.forwomenforlife.com.

Pharmanex
Pharmanex, a Nu Skin Enterprises company, applies pharmaceutical processes and scientific measurement to create nutritional supplements for more than 30 markets worldwide. Pharmanex® products are sold direct to the consumer through the Internet and a network of independent distributors. For more information, go to www.pharmanex.com.

*These statements have not been evaluated by the Food and Drug Administration. Any product mentioned in this release is not intended to diagnose, treat, cure or prevent any disease.

Home  :  Nu Skin Enterprises  :  Live Better Longer  :  Force for Good  :  Nourish the Children  :  Site Map